https://www.techtarget.com/pharmalifesciences/news/366643587/CVS-brings-back-Lillys-Zepbound-coverage-adds-obesity-pill-Foundayo 2026-05-29 TechTarget en CVS brings back Lilly's Zepbound coverage, adds obesity pill Foundayo https://www.techtarget.com/pharmalifesciences/news/366642656/Deloitte-warns-of-a-bubble-effect-caused-by-the-GLP-1-boom 2026-05-05 TechTarget en Deloitte warns of a "bubble effect" caused by the GLP-1 boom https://www.techtarget.com/pharmalifesciences/news/366642589/FDA-moves-toward-real-time-review-of-clinical-trial-data 2026-04-30 TechTarget en FDA moves toward real-time review of clinical trial data